Literature DB >> 9687334

Microfabricated microneedles: a novel approach to transdermal drug delivery.

S Henry1, D V McAllister, M G Allen, M R Prausnitz.   

Abstract

Although modern biotechnology has produced extremely sophisticated and potent drugs, many of these compounds cannot be effectively delivered using current drug delivery techniques (e.g., pills and injections). Transdermal delivery is an attractive alternative, but it is limited by the extremely low permeability of skin. Because the primary barrier to transport is located in the upper 10-15 micron of skin and nerves are found only in deeper tissue, we used a reactive ion etching microfabrication technique to make arrays of microneedles long enough to cross the permeability barrier but not so long that they stimulate nerves, thereby potentially causing no pain. These microneedle arrays could be easily inserted into skin without breaking and were shown to increase permeability of human skin in vitro to a model drug, calcein, by up to 4 orders of magnitude. Limited tests on human subjects indicated that microneedles were reported as painless. This paper describes the first published study on the use of microfabricated microneedles to enhance drug delivery across skin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687334     DOI: 10.1021/js980042+

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  178 in total

1.  Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.

Authors:  Thirupathi Reddy Yerramreddy; Mikolaj Milewski; Narsimha Reddy Penthala; Audra L Stinchcomb; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-04-18       Impact factor: 2.823

Review 2.  Microfabrication technologies for oral drug delivery.

Authors:  Shilpa Sant; Sarah L Tao; Omar Z Fisher; Qiaobing Xu; Nicholas A Peppas; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2011-12-04       Impact factor: 15.470

3.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies.

Authors:  Devin V McAllister; Ping M Wang; Shawn P Davis; Jung-Hwan Park; Paul J Canatella; Mark G Allen; Mark R Prausnitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

4.  Hollow microneedle-based sensor for multiplexed transdermal electrochemical sensing.

Authors:  Philip R Miller; Shelby A Skoog; Thayne L Edwards; David R Wheeler; Xiaoyin Xiao; Susan M Brozik; Ronen Polsky; Roger J Narayan
Journal:  J Vis Exp       Date:  2012-06-01       Impact factor: 1.355

5.  Hollow microneedle arrays for intradermal drug delivery and DNA electroporation.

Authors:  Liévin Daugimont; Nolwenn Baron; Gaëlle Vandermeulen; Natasa Pavselj; Damijan Miklavcic; Marie-Caroline Jullien; Gonzalo Cabodevila; Lluis M Mir; Véronique Préat
Journal:  J Membr Biol       Date:  2010-07-22       Impact factor: 1.843

6.  In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography.

Authors:  Siôn A Coulman; James C Birchall; Aneesh Alex; Marc Pearton; Bernd Hofer; Conor O'Mahony; Wolfgang Drexler; Boris Považay
Journal:  Pharm Res       Date:  2010-05-13       Impact factor: 4.200

7.  Microneedles for drug delivery.

Authors:  Gary W Cleary
Journal:  Pharm Res       Date:  2010-11-17       Impact factor: 4.200

Review 8.  Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.

Authors:  Michael Zakrewsky; Sunny Kumar; Samir Mitragotri
Journal:  J Control Release       Date:  2015-09-15       Impact factor: 9.776

9.  Membrane filtration: An unconventional route for fabrication of the flexible and dissolvable, polymer microneedle patches.

Authors:  Yi-Je Juang; Yu-Luen Deng; I-Chi Lee
Journal:  Biomicrofluidics       Date:  2016-08-03       Impact factor: 2.800

Review 10.  Transdermal drug delivery of insulin with ultradeformable carriers.

Authors:  Gregor Cevc
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.